内血管血栓切除术的成本效益大血管封闭性中风对于非常老年人
Peter Lee1,2, Teddy Wu3, Chushuang Chen4
1Deakin Health Economics, Deakin University School of Health and Social Development, Burwood, Victoria, Australia.
Neurology
|October 3, 2025
概括
血管内血栓切除术 (EVT) 对患有大血管封闭性中风 (LVO) 的非常老年患者来说是具有成本效益的,与标准护理相比,改善了结果并延长了寿命. 这项研究支持在这个人口群体中更广泛地采用EVT.
科学领域:
- 神经学 神经学
- 卫生经济学 卫生经济学
- 老年病的医生 老年病的医生
背景情况:
- 大血管堵塞 (LVO) 卒中对老年人影响不成比例.
- 内血管血栓切除术 (EVT) 提供了临床益处,但在澳大利亚的老年人群 (≥80岁) 中未得到充分利用.
- 需要现实世界的数据来评估EVT在老年中风患者中的价值.
研究的目的:
- 评估EVT的成本效益和临床有效性,与LVO中风的非常老年患者 (≥80岁) 的标准医疗管理相比.
- 为了利用现实世界的观察数据进行经济和临床分析.
- 为医疗保健政策提供有关老年中风幸存者的EVT提供信息.
主要方法:
- 从澳大利亚医疗保健角度对成本效益进行模拟分析.
- 利用了来自4个综合性中风中心和国际中风 perfusion 影像注册表的回顾性数据.
- 员工倾向分数匹配和决策分析马尔科夫模型来评估90天修改的兰金尺度 (mRS) 结果,成本和质量调整后生命年 (QALYs).
主要成果:
- 倾向性得分匹配显示,EVT (37%) 与标准护理 (18%) 相比,具有更高的有利结果 (mRS ≤2).
- 模拟分析估计,EVT在10,000名患者中在15年内预防了471例死亡.
- 在每QALY增加的成本效益比 (ICER) 为3,508澳元时,EVT显示每患者增加了0.95生命年和0.97QALY,远低于50,000澳元的门.
结论:
- 血管内血栓切除术 (EVT) 是一个具有成本效益的干预措施,用于患有大血管封闭 (LVO) 卒中的非常老年患者.
- EVT提供了显著的临床益处,包括改善功能结果和增加预期寿命.
- 这些发现支持在LVO中风的非常老年人群中扩大EVT的使用.
相关概念视频
Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Pharmacodynamics in Geriatric Patients: Effects of Age
187
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
187
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319


